Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. CARMUSTINE OBVIUS (carmustine)
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

CARMUSTINE OBVIUS (carmustine)

Medicine - Posted on Mar 12 2021
Active substance (DCI)
  • carmustine
history (2)
  • 3/3/21

    CARMUSTINE OBVIUS (carmustine)
    Key points Favourable opinion for reimbursement in the new MA indication. What therapeutic improvement? No clinical added va...
    CAV :
    54321
    icône flèche
  • 11/6/19

    CARMUSTINE OBVIUS (carmustine)
    Mise à disposition d'un eurogénérique. L'essentiel Avis favorable au remboursement dans les indications de l’AMM. Quel progr...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • L01AD01
Manufacturer
MEDAC
Presentation

CARMUSTINE OBVIUS 100 mg, poudre et solvant pour solution à diluer pour perfusion
1 flacon en verre de 100 mg - 1 ampoule en verre de 3 ml (CIP : 34009 550 674 9 8)

All our publications
    Drug therapy Hematologic cancers Nervous system cancers

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
yNDEMS9agSH0f34q